Nasdaq · Healthcare
CareDx, Inc. (CDNA)
As-reported financials and recent SEC filings for CareDx, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$379.8M
Net income
$-21.4M
Net margin
-5.6%
Diluted EPS
$-0.40
ROE
-7.0%
P/E (TTM)
—
Market cap
$1.49B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M |
| Gross profit | — | — | — | — | — |
| Operating income | $-30.8M | $40.8M | $-203.4M | $-77.2M | $-29.7M |
| Net income | $-21.4M | $52.5M | $-190.3M | $-76.6M | $-30.7M |
| Diluted EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →Go deeper on CDNA
Search CareDx, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.